Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT

Bone Marrow Transplantation

Volumn 48, Issue 5, 2013, Pages 698-702

  Sato, M ^a   Nakasone, H ^a   Oshima, K ^a   Ishihara, Y ^a   Wada, H ^a   Sakamoto, K ^a   Kawamura, K ^a   Ashizawa, M ^a   MacHishima, T ^a   Terasako, K ^a   Kimura, S ^a   Kikuchi, M ^a   Okuda, S ^a   Tanihara, A ^a   Yamazaki, R ^a   Tanaka, Y ^a   Kanda, J ^a   Kako, S ^a   Nishida, J ^a   Kanda, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

C reactive protein; GVHD; hematopoietic SCT; infectious events; transplant related complications

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; BUSULFAN; C REACTIVE PROTEIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; ITRACONAZOLE; MELPHALAN; METHOTREXATE; PENTAMIDINE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE MARKER; FEBRILE NEUTROPENIA; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HUMAN; HUMAN CELL; INCIDENCE; INFECTION; LEUKEMIA; LUNG ALVEOLUS PROTEINOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PNEUMOCYSTIS JIROVECI INFECTION; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84877673261     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.193     Document Type: Article

References (12)

1. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141-212.
2. Sato M, Kako S, Oshima K, Sato K, Terasako K, Kimura S et al. Prediction of infectious events by high-sensitivity C-reactive protein level before undergoing chemotherapy for acute myeloid leukaemia. Scand J Infect Dis 2010; 42: 97-101.
3. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD. Bone Marrow Transplant 1995; 15: 825-828.
4. Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T et al. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood 2012; 119: 2409-2416.
5. Nakai K, Kanda Y, Fukuhara S, Sakamaki H, Okamoto S, Kodera Y et al. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome. Leukemia 2005; 19: 396-401.
6. Remberger M, Mattsson J. C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantation. Int J Hematol 2010; 92: 161-167.
7. Artz AS, Wickrema A, Dinner S, Godley LA, Kocherginsky M, Odenike O et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 1209-1216.
8. Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2010; 46: 208-216.
9. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
10. Drahovsky D, Dunzendorfer U, Ziegenhagen G, Drahovsky M, Kellen JA. Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers. Oncology 1981; 38: 286-291.
11. Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010; 60: 409-416.
12. Koya J, Nannya Y, Ichikawa M, Kurokawa M. The clinical role of procalcitonin in hematopoietic SCT. Bone Marrow Transplant 2012; 47: 1326-1331.